Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunity and Reinfection.
作者信息
Dan Jennifer, Mehta Sanjay
机构信息
Division of Infectious Diseases and Global Health, University of California San Diego, La Jolla, California, USA.
Division of Vaccine Discovery, La Jolla Institute for Immunology (LJI), La Jolla, California, USA.
出版信息
Clin Infect Dis. 2021 Nov 2;73(9):e2992-e2994. doi: 10.1093/cid/ciaa1936.
Abstract
摘要
相似文献
1
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunity and Reinfection.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）免疫与再感染
Clin Infect Dis. 2021 Nov 2;73(9):e2992-e2994. doi: 10.1093/cid/ciaa1936.
2
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.巴西再次感染 SARS-CoV-2 患者的遗传证据和宿主免疫反应
Emerg Infect Dis. 2021 May;27(5):1446-1453. doi: 10.3201/eid2705.204912. Epub 2021 Apr 12.
3
Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.密歇根家庭流感疫苗评估（HIVE）队列中冠状病毒的发生：再感染频率和对季节性和严重急性呼吸综合征冠状病毒的血清学反应。
J Infect Dis. 2021 Jul 2;224(1):49-59. doi: 10.1093/infdis/jiab161.
4
Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in a University Student Population.大学生群体中严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）再感染的风险。
Clin Infect Dis. 2022 Mar 1;74(4):719-722. doi: 10.1093/cid/ciab454.
5
Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020.2020 年 5 月至 7 月期间可能发生严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）再感染患者的临床和实验室发现。
Clin Infect Dis. 2021 Dec 16;73(12):2217-2225. doi: 10.1093/cid/ciab148.
6
Symptomatic COVID-19 Reinfection with Pericardial and Pleural Involvement.有症状的 COVID-19 再感染伴心包和胸膜累及。
J Pak Med Assoc. 2022 Jan;72(1):171-173. doi: 10.47391/JPMA.11-2438.
7
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.基因组证据表明巴西出现涉及 Spike 蛋白 E484K 突变的 SARS-CoV-2 再感染。
Emerg Infect Dis. 2021 May;27(5):1522-1524. doi: 10.3201/eid2705.210191. Epub 2021 Feb 19.
8
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.在高强度再暴露环境下评估严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）再感染的风险。
Clin Infect Dis. 2021 Oct 5;73(7):e1830-e1840. doi: 10.1093/cid/ciaa1846.
9
Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report.严重急性呼吸综合征冠状病毒 2 型在 2019 冠状病毒病康复的年轻成年人中的再感染：一例报告。
J Med Case Rep. 2021 Jul 16;15(1):382. doi: 10.1186/s13256-021-02965-5.
10
A Case of Early Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).一例严重急性呼吸综合征冠状病毒2（SARS-CoV-2）早期再次感染病例。
Clin Infect Dis. 2021 Nov 2;73(9):e2827-e2828. doi: 10.1093/cid/ciaa1436.
引用本文的文献
1
Recurrence of COVID-19 associated with reduced T-cell responses in a monozygotic twin pair.COVID-19 复阳与同卵双胞胎 T 细胞反应下降有关。
Open Biol. 2022 Feb;12(2):210240. doi: 10.1098/rsob.210240. Epub 2022 Feb 2.
2
From SIR to SEAIRD: A novel data-driven modeling approach based on the Grey-box System Theory to predict the dynamics of COVID-19.从SIR到SEAIRD：一种基于灰箱系统理论的新型数据驱动建模方法，用于预测新冠疫情动态。
Appl Intell (Dordr). 2022;52(1):71-80. doi: 10.1007/s10489-021-02379-2. Epub 2021 Apr 23.
3
Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study.基线 SARS-CoV-2 抗体状况对症状监测和随后 COVID-19 风险的影响——一项前瞻性多中心队列研究。
BMC Med. 2021 Oct 14;19(1):270. doi: 10.1186/s12916-021-02144-9.
4
Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2-infected individuals reveal unlinked immune signatures.无症状和有症状的新冠病毒感染者的全身和黏膜免疫分析揭示了不相关的免疫特征。
Sci Adv. 2021 Oct 15;7(42):eabi6533. doi: 10.1126/sciadv.abi6533. Epub 2021 Oct 13.
5
Repeat positive SARS-CoV-2 RNA testing in nursing home residents during the initial 9 months of the COVID-19 pandemic: an observational retrospective analysis.COVID-19大流行最初9个月期间疗养院居民中SARS-CoV-2 RNA检测反复呈阳性：一项观察性回顾性分析
Lancet Reg Health Am. 2021 Nov;3:100054. doi: 10.1016/j.lana.2021.100054. Epub 2021 Aug 21.
6
SARS-CoV-2 re-infection risk in Austria.奥地利的 SARS-CoV-2 再感染风险。
Eur J Clin Invest. 2021 Apr;51(4):e13520. doi: 10.1111/eci.13520. Epub 2021 Feb 21.
Zotero 插件